Cyano Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.94 M
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.75 Cr
- Satisfied Charges ₹ 2.29 Cr
- Revenue Growth -3.53%
- Profit Growth -15.16%
- Ebitda 433.30%
- Net Worth 7.04%
- Total Assets -5.92%
About Cyano Pharma
Cyano Pharma Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 February 2000 and has a history of 24 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.94 M.
The company currently has active open charges totaling ₹17.75 Cr. The company has closed loans amounting to ₹2.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MH2000PTC283629
-
Company No.
283629
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Feb 2000
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Cyano Pharma Private Limited offer?
Cyano Pharma Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream.
Who are the key members and board of directors at Cyano Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sureshchandra Chourasiya
|
Director | 01-Sep-2010 | Current |
|
Mahendra Patidar
|
Director | 10-Mar-2023 | Current |
Financial Performance of Cyano Pharma.
Cyano Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.53% decrease. The company also saw a substantial fall in profitability, with a 15.16% decrease in profit. The company's net worth moved up by a moderate rise of 7.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyano Pharma?
In 2022, Cyano Pharma had a promoter holding of 7.35% and a public holding of 92.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹177.50 M
₹22.88 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 15.57 Cr
- Sidbi : 2.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2023 | Sidbi | ₹2.18 Cr | Open |
| 19 Oct 2020 | State Bank Of India | ₹1.70 M | Open |
| 05 Mar 2004 | State Bank Of India | ₹15.40 Cr | Open |
| 01 Jun 2020 | State Bank Of India | ₹9.40 M | Satisfied |
| 28 Apr 2020 | State Bank Of India | ₹1.00 Cr | Satisfied |
How Many Employees Work at Cyano Pharma?
Cyano Pharma has a workforce of 31 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyano Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyano Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
